|
|
||||||||
From the Molecular Pharmacology Unit, Glaucoma Research, Alcon Research, Ltd., Fort Worth, Texas.
PURPOSE. To determine the functional agonist potencies of the intraocular pressure (IOP)-lowering prostaglandin F (FP)-class prostaglandin (PG) analogues (e.g., travoprost, latanoprost, bimatoprost, and unoprostone isopropyl ester) in human trabecular meshwork (h-TM) cells, by using phosphoinositide (PI) turnover and intracellular Ca2+ ([Ca2+]i) mobilization, and to confirm the FP nature of these receptors by using an FP receptor antagonist, 11ß-fluoro-15-epi-15-indanyl-PGF2
(AL-8810).
METHODS. FP-receptor-mediated PI turnover and [Ca2+]i mobilization were measured in h-TM cells by determining the accumulation of [3H]-inositol phosphates ([3H]-IPs) by anion-exchange chromatography and real-time fluorescence imaging, respectively.
RESULTS. Various PG analogues concentration-dependently stimulated production of [3H]-IPs in h-TM cells with the following agonist potencies (median effective concentration; EC50): travoprost acid (EC50 = 2.4 nM) > cloprostenol (EC50 = 4.5 nM) > (±)-fluprostenol (EC50 = 10.8 nM) > latanoprost acid (EC50 = 34.7 nM) > bimatoprost acid (EC50 = 112 nM) > PGF2
(EC50 = 120 nM) >> unoprostone (UF-021; EC50 = 3280 nM) > S-1033 (EC50 = 4570 nM; all n = 39). Prodrug derivatives of these compounds exhibited the following potencies: travoprost (isopropyl ester; EC50 = 89.1 nM) > latanoprost (isopropyl ester; EC50 = 778 nM) > bimatoprost (amide; EC50 = 14106940 nM). Travoprost acid, PGF2
, unoprostone, and S-1033 were tested in addition for [Ca2+]i mobilization and found to have rapid and dose-dependent effects. The FP receptor-selective antagonist AL-8810 antagonized the (±)-fluprostenol-induced PI turnover in these cells (Ki = 2.56 ± 0.62 µM) as well as that induced by bimatoprost and acids of latanoprost and travoprost. The agonist and antagonist potencies of the PG analogues from the PI turnover assays in h-TM cells correlated well with PI turnover data obtained from the cloned human ciliary body FP receptor (r = 0.92; P < 0.0001).
CONCLUSIONS. The pharmacology of the h-TM cell FP-receptor-mediated PI turnover and [Ca2+]i mobilization was defined using numerous synthetic (FP-selective) PG agonist analogues and an FP receptor antagonist, AL-8810. Bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester, and their respective free acids were shown to be FP agonists in the h-TM cells.
This article has been cited by other articles:
![]() |
C B Camras, N A Sharif, M B Wax, and J Stjernschantz Bimatoprost, the prodrug of a prostaglandin analogue Br. J. Ophthalmol., June 1, 2008; 92(6): 862 - 863. [Full Text] [PDF] |
||||
![]() |
L B Cantor Author's reply Br. J. Ophthalmol., June 1, 2008; 92(6): 863 - 864. [Full Text] [PDF] |
||||
![]() |
R.-F. Wang, D. J. Gagliuso, T. W. Mittag, and S. M. Podos Effect of 15-Keto Latanoprost on Intraocular Pressure and Aqueous Humor Dynamics in Monkey Eyes Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4143 - 4147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Romano and M. D. Lograno Evidence for the Involvement of Cannabinoid CB1 Receptors in the Bimatoprost-Induced Contractions on the Human Isolated Ciliary Muscle Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3677 - 3682. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B Cantor, J. Hoop, D. Wudunn, C.-W. Yung, Y. Catoira, S. Valluri, A. Cortes, A. Acheampong, D. F Woodward, and L. A Wheeler Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract Br. J. Ophthalmol., May 1, 2007; 91(5): 629 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-J. Oh, J. L. Martin, A. J. Williams, P. Russell, D. E. Birk, and D. J. Rhee Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3887 - 3895. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Sharif, C. R. Kelly, and M. McLaughlin Human Trabecular Meshwork Cells Express Functional Serotonin-2A (5HT2A) Receptors: Role in IOP Reduction. Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 4001 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Thieme, C. Schimmat, G. Munzer, M. Boxberger, M. Fromm, N. Pfeiffer, and R. Rosenthal Endothelin Antagonism: Effects of FP Receptor Agonists Prostaglandin F2{alpha} and Fluprostenol on Trabecular Meshwork Contractility. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 938 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Crowston, J. D. Lindsey, C. A. Morris, L. Wheeler, F. A. Medeiros, and R. N. Weinreb Effect of Bimatoprost on Intraocular Pressure in Prostaglandin FP Receptor Knockout Mice Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4571 - 4577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, M. Aihara, S. Narumiya, and M. Araie The Effects of Prostaglandin Analogues on IOP in Prostanoid FP-Receptor-Deficient Mice Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4159 - 4163. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ota, H. Murata, E.-i. Sugimoto, M. Aihara, and M. Araie Prostaglandin Analogues and Mouse Intraocular Pressure: Effects of Tafluprost, Latanoprost, Travoprost, and Unoprostone, Considering 24-Hour Variation Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Husain, F. Jafri, and C. E. Crosson Acute Effects of PGF2{alpha} on MMP-2 Secretion from Human Ciliary Muscle Cells: A PKC- and ERK-Dependent Process Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1706 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Gagliuso, R.-F. Wang, T. W. Mittag, and S. M. Podos Additivity of Bimatoprost or Travoprost to Latanoprost in Glaucomatous Monkey Eyes Arch Ophthalmol, September 1, 2004; 122(9): 1342 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Nirodi, B. C. Crews, K. R. Kozak, J. D. Morrow, and L. J. Marnett The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells PNAS, February 17, 2004; 101(7): 1840 - 1845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |